Replies to post #18153 on The Rising Influence of Rising Affluence

[DewDiligence]

ABT starts pivotal trial to expand MitraClip label to include patients at moderate risk for open-heart surgical repair:

https://finance.yahoo.com/news/abbott-initiate-trial-study-mitraclip-140000291.html

MitraClip is already a bona fide blockbuster product with rapid growth from the FDA’s Mar 2019 label expansion to secondary mitral regurgitation (#msg-147544267). The potential label expansion from the new trial described above would materially move the needle even further.